nplooj ntawv_banner

khoom

Chaw tsim tshuaj Nefiracetam hmoov CAS No.: 77191-36-7 99% purity min. rau cov khoom xyaw ntxiv

Kev Piav Qhia Luv:

Nefiracetam yog ib hom tshuaj uas tsis yog ciam teb rau kev txhim kho kev txawj ntse, uas muaj cov qauv tshuaj sib txawv thiab txhim kho kev muaj peev xwm paub thiab tiv thaiv kev puas tsuaj ntawm kev kawm thiab kev nco los ntawm lawv cov teebmeem rau lub hlwb cortex.


Cov Khoom Qhia Txog Khoom

Cov Cim Npe Khoom

Cov Yeeb Yaj Kiab Txog Khoom

Cov Khoom Siv

Lub npe khoom

Nefiracetam

Lwm lub npe

n-(2,6-dimethylphenyl)-2-oxo-1-pyrrolidineacetamide;NEFIRACETAM;

2-oxo-1-pyrrolidinylaceticacid,2,6-dimethylanilide;

dm9384;

n-(2,6-dimethylphenyl)-2-oxo-1-pyrrolidineacetamid;DM-9384,(2-(2-Oxopyrrolidin-1-yl)-N-(2,6-dimethylphenyl)-acetamide);

DMMPA

CAS Nr.

77191-36-7

Cov mis molecular

C14H18N2O2

Qhov hnyav ntawm cov molecule

246.3

Kev dawb huv

99.0%

Qhov tsos

Hmoov dawb

Ntim khoom

25 kg/phaj

Daim Ntawv Thov

nootropic tshuaj

Kev taw qhia txog khoom

Nefiracetam yog ib hom tshuaj uas muaj npe nrov rau nws cov khoom ua rau lub hlwb ua haujlwm tau zoo. Nefiracetam tau tsim thawj zaug thaum xyoo 1980s thiab tau txais kev saib xyuas sai sai vim nws txoj kev ua haujlwm tshwj xeeb thiab kev siv tshuaj kho mob. Cov tshuaj racemic no xav tias cuam tshuam rau cov neurotransmitters thiab receptors hauv lub hlwb, thaum kawg txhawb kev txhim kho kev txawj ntse. Nefiracetam feem ntau cuam tshuam rau cov theem ntawm acetylcholine hauv lub hlwb, ib qho neurotransmitter tseem ceeb uas yog lub luag haujlwm rau kev nco, kev kawm, thiab kev ua haujlwm ntawm lub hlwb. Los ntawm kev hloov kho acetylcholine receptors, nefiracetam txhawb kev sib txuas lus ntau ntxiv ntawm cov neurons, yog li ua kom synaptic plasticity thiab txhim kho kev nco. Tsis tas li ntawd, nefiracetam cuam tshuam nrog gamma-aminobutyric acid (GABA) receptors los pab sib npaug ntawm cov neurotransmitter milieu. Los ntawm kev cuam tshuam zoo rau cov neurotransmitters excitatory thiab inhibitory, nefiracetam pab tswj kev ua haujlwm ntawm lub hlwb zoo tshaj plaws, yog li txhim kho kev tsom mus rau, kev mloog zoo, thiab kev ua haujlwm ntawm lub hlwb tag nrho.

Feature

(1) Kev ntshiab siab: Nefiracetam tuaj yeem tau txais cov khoom ntshiab siab los ntawm kev ua kom huv. Kev ntshiab siab txhais tau tias muaj kev nyab xeeb zoo dua thiab muaj tsawg dua cov kev tsis zoo.

(2) Kev Nyab Xeeb: Kev nyab xeeb siab, ob peb qhov kev tsis haum.

(3) Kev Ruaj Ntseg: Nefiracetam muaj kev ruaj ntseg zoo thiab tuaj yeem tswj nws cov haujlwm thiab cov txiaj ntsig nyob rau hauv ntau qhov chaw sib txawv thiab cov xwm txheej cia khoom.

Cov ntawv thov

Nefiracetam yog ib qho hydrophobic derivative ntawm piracetam, uas feem ntau suav hais tias yog ib yam khoom uas muaj lub luag haujlwm rau kev tshawb pom cov calcium channels hauv lub cev thiab kev hloov pauv tsis ncaj qha ntawm cov tshuaj signaling excitatory ua ib feem agonist ntawm calcium ion channels. Glycine binding site ntawm NDMA receptor. Los ntawm nws cov nyhuv rau lub cerebral cortex, nefiracetam tuaj yeem txhim kho lub peev xwm paub thiab tiv thaiv kev kawm thiab kev nco tsis zoo. Nws tsis muaj muscarinic receptor agonist lossis antagonist cov khoom, thiab nws tsis inhibit acetylcholinease kev ua ub no. Yog li ntawd, nws cov teebmeem tiv thaiv kev nco thiab kev txhim kho kev nco tau ua tiav los ntawm kev txhim kho kev tso tawm ntawm acetylcholine hauv lub cerebral cortex.


  • Yav dhau los:
  • Tom ntej no:

  • Sau koj cov lus ntawm no thiab xa tuaj rau peb